GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NeuBase Therapeutics Inc (STU:O7P) » Definitions » Float Percentage Of Total Shares Outstanding

NeuBase Therapeutics (STU:O7P) Float Percentage Of Total Shares Outstanding : 93.39% (As of May. 24, 2024)


View and export this data going back to 2019. Start your Free Trial

What is NeuBase Therapeutics Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, NeuBase Therapeutics's float shares is 3.50 Mil. NeuBase Therapeutics's total shares outstanding is 3.75 Mil. NeuBase Therapeutics's float percentage of total shares outstanding is 93.39%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, NeuBase Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, NeuBase Therapeutics's Institutional Ownership is 0.56%.

NeuBase Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

NeuBase Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=3.50/3.75
=93.39%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeuBase Therapeutics (STU:O7P) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NeuBase Therapeutics Inc (STU:O7P) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
IBIO ENDV INM CYCC FWBI QLGN VRAX ADTX SCNI GBLX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XKRX:068270 BNTX ALNY
Traded in Other Exchanges
NBSE:USA O7P:Germany
Address
350 Technology Drive, Suite 421, Pittsburgh, PA, USA, 15219
Website
https://www.neubasetherapeutics.com
NeuBase Therapeutics Inc is a pre-clinical stage biopharmaceutical company. It is engaged in the development of gene silencing therapies with its synthetic antisense oligonucleotides. Its Patrol platform is focused on the development of drugs for rare genetic diseases such as Huntington's Disease, Myotonic Dystrophy and Familial Parkinson's Disease among others.

NeuBase Therapeutics (STU:O7P) Headlines

No Headlines